Biotech Values

[gdollasign]

Ref: www.clinicaltrials.gov/ct2/show/NCT02130557

Thanks to jaybe on SI:

http://www.siliconinvestor.com/readmsg.aspx?msgid=29665757

I would think that if the 30mg ponatinib study that began in 2012 by Dr.C is successful in alleviating the SAE's with continued BIC efficacy then the Bosulif study will turn out to be a waste of time imo. I am betting on Dr Cortes to figure it out as he had seemingly done a long time ago as I recall from previous data.

I am not in ARIA anymore but will be at some point if it flushes again.

G$